Sign in to view Terry’s full profile
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
Sign in to view Terry’s full profile
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
United States
Sign in to view Terry’s full profile
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
2K followers
500+ connections
Sign in to view Terry’s full profile
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
View mutual connections with Terry
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
View mutual connections with Terry
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
Sign in to view Terry’s full profile
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
Websites
- Company Website
-
http://www.moorevp.com
- Company Website
-
http://www.thevcroundtable.com
Articles by Terry
-
In Case You Missed It - The State Of Venture Capital Presentation January 5, 2016
In Case You Missed It - The State Of Venture Capital Presentation January 5, 2016
The venture capital industry has rebounded nicely and is thriving in just about all markets except for San Diego. Come…
4
1 Comment -
The State Of Venture Capital In San DiegoDec 7, 2015
The State Of Venture Capital In San Diego
Come hear the history, current state, and the economic importance of venture capital in our community. This…
3
-
See me in a New TV Show "Make Me A Millionaire Inventor" on CNBC Tonight 10pm - Glo-Blades Episode!Aug 26, 2015
See me in a New TV Show "Make Me A Millionaire Inventor" on CNBC Tonight 10pm - Glo-Blades Episode!
Check out a new TV show I am in as the Investor called "MAKE ME A MILLIONAIRE INVENTOR" on CNBC tonight at 10:00pm! I…
2
1 Comment -
Third Annual VC RegattaMay 27, 2015
Third Annual VC Regatta
The Third Annual VC Regatta will be held in San Diego on July 23, 2015. Please contact me at terry@thevcroundtable.
1
-
MVP Fund II Closing In One MonthMay 27, 2015
MVP Fund II Closing In One Month
The final close of MVP VC Fund II will be June 30, 2015. Please contact me at terry@moorevp.
1
-
MVP Fund II ClosingApr 29, 2015
MVP Fund II Closing
Due to the strong performance of MVP (Moore Venture Partners) Fund I (up 3.2X since final close in April of 2013) - We…
11
2 Comments
Activity
2K followers
-
-
Terry Moore shared thisVery exciting - Super Congrats Mike !!Terry Moore shared thisI am beyond ecstatic to be a part of this announcement: San Diego has a new $50M venture capital fund. I have been a longtime admirer of Prebys Foundation. The history of their efforts can be seen far and wide across our region. They've made our lives better. And the Prebys Ventures Impact Fund is further demonstration of their leadership: they're innovative, and they execute. With this fund, we are going to help advance economic prosperity, across the megaregion, for future generations of families. It's been an honor and a responsibility to lead Connect for the past ten years. That organization remains as important as ever to the innovation economy. I couldn't be happier that these two organizations will continue to work together. The opportunity in front of the "collective us" is enormous. Broad-based Innovation economies will be a defining feature of tomorrow's great regions. And San Diego has all the pieces - we just need a shared vision, and a willingness to execute. So that's what we're going to do. Together, we're going to create a better San Diego. Looking forward to the barrage of deal flow, and the inevitable winning outcomes!! Let's do this!!! https://lnkd.in/gEShj9SZBy investing in companies in the tech and life sciences sectors, the fund is poised to strengthen San Diego’s economy and create lasting opportunities for local communities.By investing in companies in the tech and life sciences sectors, the fund is poised to strengthen San Diego’s economy and create lasting opportunities for local communities.
-
Terry Moore shared thishttps://lnkd.in/gNDHKzbC
-
Terry Moore shared thisThanks for organizing this event for the Cloudbeds team Carlos - What a great team you’ve put together, Adam & RichTerry Moore shared thisFOMO! Richard Castle joined more than 55 of our Cloudbeds colleagues who gathered on their own time and dime in Medellín, Colombia. One teammate—customer support QA analyst Luis Miguel Cardona Ortiz — took a 10.5-hour bus ride just to be with the group. This was all the result of thoughtful planning from Carlos Avendaño Mora. This is the power of Cloudbeds. Team members from other countries, other cultures, who stay connected and create moments to be together. There’s more to these events than meets the eye. Gathering reminds us of our shared purpose, values and love for travel! Sound like a team you want to be a part of? Join us!! >> https://lnkd.in/guJdZgB
-
-
-
Terry Moore shared thisYou're invited to the virtual VC Roundtable on MARCH 9th at 11:30am PT - To Register click on the following link and follow the steps in order to receive your Zoom link: #venturecapital #entrepreneurs #mvpfunds #vcroundtable #mooreventurepartners https://lnkd.in/dRgnbAN4
-
Terry Moore liked thisTerry Moore liked thisI am excited to announce that I have joined Berg Hill Greenleaf Ruscitti LLP as a partner in the corporate group, where I will continue my M&A and venture capital law practice. I have worked opposite BHGR on prior M&A transactions, and I am excited for what we can do for our clients together. I will miss working with my colleagues at CCG, to whom I am grateful for making CCG my work home for the past 10 years.
-
Terry Moore liked thisTerry Moore liked thisToday is one of those unforgettable days that defines a life’s work. I’m delighted to announce the FDA has granted Kura Oncology, Inc. full approval for our menin inhibitor for adults with relapsed or refractory NPM1-mutant Acute Myeloid Leukemia (AML). This milestone is a shared triumph: one made possible by the unwavering trust of AML patients and their families, the dedication of investigators and care teams who pushed forward for patients, relentless advocates who gave voice to the need for progress, and the passion, focus and dedication of #TeamKura, who persevered throughout more than a decade of work. Today begins a new chapter in AML treatment. Our commitment to advancing menin inhibition research – through innovative combinations and in earlier lines of therapy – burns as brightly as ever. We’re forging ahead with the same urgency and commitment to patients that brought us here. My heartfelt gratitude and congratulations to everyone who made this moment possible. https://lnkd.in/gHFw5DMf
-
Terry Moore liked thisTerry Moore liked thisWe hosted our first ever Founders & Co. meet up this morning in Encinitas. Stoked to see so many intrepid San Diego founders journey out into the storm* this morning to meet up at Surfdog's Java Hut to share what they're building and talk about CRMs, founder led sales, LinkedIn posting strategies, and brick and mortar businesses. We'll do it again soon! *Some coastal cloud cover down by the beach mixed with light intermittent sprinkles.
Experience & Education
-
MVP Funds & Moore Venture Partners
******** *******
-
*** ** **********
******** * *******
-
******** * ******** ******* *******
********* ********
-
********** ** *** *****
****** ******* ********** *** ********* undefined
-
-
********** ** *******
**** *********** ********* ******* *** ***********
-
View Terry’s full experience
See their title, tenure and more.
Welcome back
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
New to LinkedIn? Join now
or
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
View Terry’s full profile
-
See who you know in common
-
Get introduced
-
Contact Terry directly
Other similar profiles
Explore more posts
-
Todd Thomson
Kairos Ventures • 8K followers
NanoClear Technologies has secured exclusive global rights to Atomic Layer Polishing from Caltech and JPL. They're unlocking a breakthrough platform that could redefine what's possible in precision manufacturing—across semiconductors, optics, aerospace, and beyond. Excited to watch this deep tech innovation scale.
4
-
Henry D. Wolfe
DaVega & Wolfe Industries… • 1K followers
Hexcel Adds Independent Director in Deal With Activist Investor "Hexcel added a new independent director to its board in a move that avoids a potential proxy fight for the aerospace materials company with activist investor Vision One Fund. "As part of an agreement between the two sides, Vision One will withdraw their nominees to the board that were to be voted on at the company's annual shareholder meeting. Vision One will also support Hexcel's board nominees, and agree to certain standstill restrictions and mutual non-disparagement provisions, according to a filing with the Securities and Exchange Commission on Wednesday. "The new director, former Kaman Chief Executive Officer Neal Keating, was appointed effective Tuesday." Keating's experience in aerospace may make him an ideal director choice. Yet from a bigger picture perspective, I wonder if this settlement is the right move for investors. More and more activist campaigns are settling rather than running the full process of a proxy fight with typically a greater number of directors nominated by the activist. Hopefully, activists are becoming like the public company boards they battle, i.e. more focused on reaching consensus than big results. #governancearbitrage #proxyfights #corporategovernance #activistinvesting #valuecreation https://lnkd.in/gazBUGFp
4
-
Jake (JH) P.
ARKITEKT EQUITY • 1K followers
Excited to finally share what we’ve been building over the past year. Today we’re announcing the first investment from ARKITEKT EQUITY. Over the past year, we have been closely observing the structural shifts occurring within semiconductor ecosystems. As manufacturing systems become more complex, the infrastructure enabling those systems becomes increasingly strategic. These environments demand operational clarity, coordination, and long-term alignment. ARKITEKT was built around a simple idea: durable value is created where frontier technology meets pragmatic execution. Our investment in BBTech reflects this conviction. This is just the beginning of what we aim to build at ARKITEKT EQUITY. Stay tuned! https://lnkd.in/g_pQiBZY
7
-
Rick Bacon
Aqua Metrology Systems Limited • 3K followers
✋ It wasn't us - honest truth! It was not by AMS's design or request that an article (p16) that promotes a legacy technology for removing carcinogenic hexavalent chromium but that includes both an image of the trucks that would be required to transport weekly thousands of gallons toxic waste from dozens of local communities to specialized treatment sites and also a 'health warning' from Ecolab that the technology may also generate radioactive waste was placed alongside a fact-based article (page 19) that compares competing treatment technologies. That article systematically addresses why these legacy technologies are not fit for pupose. This also calls into serious question why some leading consulting engineers continue to promote these legacy technologies rather than offering Californian communities the option of an approved and proven solution that has a 40% lower lifetime cost. Thank you CA-NV AWWA for giving us a voice to address this situation which risks imposing unacceptable and avoidable costs on 5 million Californian consumers, many of whom live in underserved communities and who depend on water contaminated by hexavalent chromium. #gatekeepers #barrierstoinnovation #safedrinkingwater https://lnkd.in/gdr_Xjub
15
-
Rod Matheson
Marvel Biosciences Corp. • 1K followers
Years in the making and another one granted. At Marvel Biosciences, we’ve received confirmation that the Japan Patent Office has granted a composition-of-matter patent covering our lead therapeutic candidate, MB-204. Japan follows China, as the second major jurisdiction to grant core composition-of-matter protection for MB-204, with additional major jurisdictions currently under review and to follow- stay tuned. This milestone reflects years of focused scientific work and disciplined execution at Marvel Biosciences. In particular, we want to acknowledge the leadership of our CSO, Mark Williams, whose deep experience in drug and clinical development has been instrumental in advancing MB-204 into a clinic-ready asset. This work would not be possible without our collaborators. We are grateful to the team at the iBraiN Institute, Dr. Julie Le Merrer and Dr. Jerome Becker, for their excellent preclinical work in autism and Rett syndrome models, and to the FRAXA Research Foundation for plans to evaluate MB-204 in the Fmr1 model of Fragile X syndrome. Of course, a patent is not the finish line. The goal for Marvel Biosciences is a safe, effective therapy that can make a meaningful difference for patients and families affected by autism spectrum disorder and related neurodevelopmental conditions. But today, this milestone matters and we’re proud of the team and partners who made it possible. Onward.
44
8 Comments -
Santi Dominguez
SciY • 5K followers
At SciY we are working hard to enhance the capability of our customers to handle data in #HighThroughput, to accelerate their R&D. We are delighted that Raymond Lieu, of Genentech, has agreed to discuss how they use these modules of the Mestrelab Research S.L.#mgears platform Raymond Lieu, Analytical Chemist at Genentech, discusses how automated peak‑tracking, centralized data, and standardized outputs unlock faster, more reliable AI/ML for high‑throughput LC‑MS in “Enhancing High‑Throughput LC‑MS Workflows: From Mass Peak Tracking to AI/ML Integration with Chrom RO”. Watch on‑demand now ➡️ https://lnkd.in/eXysbuw4 SciY #SciY #DrugDiscovery #Chromatography #MassSpec
9
-
Luca Longobardi
Park Avenue Capital • 9K followers
Terra Innovatum and GSR III Acquisition Corp. File Form S-4 After Business Combination Announcement Advancing Public Listing. Transaction To Accelerate Terra Innovatum’s Pathway to Commercialization of Groundbreaking Micro-Modular Nuclear Technology by 2028. https://lnkd.in/eNpGF9bU
36
4 Comments -
Steve Kiser
Veteran Ventures Capital • 6K followers
Materials science is the unsung hero of modern innovation. It enables lighter aircraft, stronger infrastructure, faster electronics, stealthier platforms, higher endurance ships and satellites, and more resilient energy systems. New designs, new software, robotics/cobots, etc. get a lot of the attention--but by engineering materials at the atomic and nano scale, we can unlock performance gains that those other technologies can’t achieve alone. Cambium is a perfect example of a top-notch team taking deep materials technology to a place that matters. Using AI and a proprietary library of molecular structures that confers certain characteristics to material properties, this team is literally creating new, bespoke matter. That creates enduring economic and battlefield advantages that are simply unmatched. Using this raise to acquire SHD Composite Materials, a materials company with large manufacturing facilities in the UK, Europe and the US, Cambium is now serving private sector clients and the defense needs of the US and her NATO allies. Deep tech -> product -> manufacturing at scale = innovation that matters.
30
-
Nora Cohen Brown
Charm Industrial • 2K followers
🚨California Takes Action with Passage of 3 Bills to Scale CDR Innovation This weekend, California made unprecedented progress in creating compliance mechanisms to help grow Carbon Dioxide Removal (CDR) by providing pathways for all CDR approaches to gain market traction and grow responsibly in the state: ✅ CDR is included for the first time in the Cap & Invest program via AB1207, which creates a pathway for CDR to be permanently integrated as a compliance offset category ✅ The Greenhouse Gas Reduction Fund was reauthorized via SB804, and now includes a framework for CDR to be included in future allocations from the fund for climate tech innovation, including as part of an $85M climate tech innovation program ✅ The passage of SB643 creates a Carbon Dioxide Removal Purchase Program to purchase CDR credits from eligible suppliers With these actions, California has created the framework to responsibly scale CDR, creating both economic and environmental benefits for Californians. These benefits include addressing affordability by generating good paying jobs and lowering CDR technology costs, as well as deploying technologies that tackle critical challenges such as wildfire fuel load reduction (such as the pictured Charm pilot in the Inyo National Forest) and orphaned wells. In addition, this program is technology-inclusive - enabling the state to deploy a wide range of technologies that support meeting CA’s climate goals by tackling legacy and residual emissions. Over the past few years, Charm Industrial has been collaborating with legislators, the California Air Resources Board (CARB), and numerous NGO, industry, and academic partners to explore these concepts - what is the right mix of technologies for California? How can CDR help plug the gaps for residual and hard to abate emissions, and what are the benefits for Californians? We are incredibly proud of this progress, and this suite of new mechanisms provides support for R&D, supply, and demand, which together will support the scaling of the CDR industry - coupled with additional resources allocated to CARB for scaling SB905, the Carbon Capture Removal and Storage bill passed in 2022, which provides the framework to support this work. This is also yet another example of California leading the nation by fully integrating responsible CDR into its programs, creating a huge opportunity for the state to lead on scaling a wide range of technologies that will not only create environmental and economic benefits, but are also critical to helping the state stay on track for net zero and reaching California’s climate goals. Thank you to our partners in the legislature and agencies for your vision and commitment to scaling these solutions, and to all of our NGO, industry, and academic partners for all of the painstaking work to come up with the right set of solutions for California. We’re looking forward to working together to implement these important programs!
104
4 Comments -
Wally Wang
NYU Stern School of Business • 14K followers
We at SAV (Scale Asia Ventures) honored to share that Advanced Research Projects Agency for Health (ARPA-H) has awarded our portfolio company Kernal Biologics up to $48 million to accelerate its in vivo CAR-T therapies toward the clinic. This milestone fuels Kernal’s mission to make treatments for hematological cancers and autoimmune diseases more tolerable, affordable, and accessible—powered by their proprietary platform in genetic medicine. We’re proud to support Kernal Biologics as they continue to push the boundaries of precision medicine and transform the future of patient care. #ARPAH #invivoCART #biotech #geneticmedicine #KernalBio
8
1 Comment -
Nate Loewentheil
Commonweal Ventures • 13K followers
#AmTech Weekly Roundup: Varda Space Industries raised $187 million in Series C funding from Shrug Capital, Founders Fund, Khosla Ventures, Caffeinated Capital, Lux Capital, and Also Capital (Mike Annunziata). Varda designs and operates spacecraft that can manufacture pharmaceuticals and advanced crystals in microgravity before returning them to Earth safely. Will Bruey, Delian Asparouhov, Daniel Marshall MaintainX raised $150 million in Series D funding at a $2.5 billion valuation from Bessemer Venture Partners, Bain Capital Ventures, The D. E. Shaw Group Ventures, and others. MaintainX is an AI-powered maintenance platform for manufacturers, schools, hospitality, and other industries with large physical footprints. Chris Turlica, Hugo Dozois-Caouette Polimorphic raised $18.6 million in Series A funding from General Catalyst, M13, and Shine Capital. Polimorphic is building an AI-powered CRM for local governments to automate workflows and improve citizen experiences. Parth Shah #VC #Startups #GovTech #Space #Unicorn
26
4 Comments -
Juliesta E. Sylvester, Ph.D.
Woodside Capital Partners • 4K followers
Spatial omics is one of the hottest applications in life sciences right now - deep tech that captures biology in time and space. It is measurement in action, not a static blueprint of possibility. If you analyze the market only by application players - those companies branding themselves as "spatial biology" or "omics" - you miss the big picture. The success of spatial omics doesn't depend on creating new business models. These are familiar models - instruments, services, software, IT - NOW powering new applications. Spatial omics sits at the intersection of: - Lab services - Software platforms - Microscopy & optics - Computational infrastructure - Data analysis Those are established industries with scaled players, distribution, and capital. Many of these established players are structurally better positioned to expand into spatial omics than companies built purely around the application label. It's so important to note that success here won't come from forcing new business models onto the science. We've seen big public missteps demonstrating how misalignment between technology, business model, and integration logic destroy value - even when the science is compelling. The real question for builders, investors, & Corp Dev isn't who calls themselves "spatial" or "multi-omic." It's who already has the technical depth & business model leverage to extend into it and make it durable. This work was developed together with Joseph Galasso - grateful for the collaboration.
12
-
Bill Carpou
Octane OC • 17K followers
I am so pleased to announce this partnership that is so complimentary to both organizations members, partners, and sponsors. Also, thanking the Biocom senior team led by Tim Scott for aligning our visions on how impactful this can be across the entire state of California. For anyone who wants to learn more and the impact this partnership will create reach out to either the Octane or Biocom teams. AbbVie Allergan Aesthetics, an AbbVie Company Medtronic Alcon Johnson & Johnson MedTech Edwards Lifesciences Bausch + Lomb STAAR Surgical Tarsus Pharmaceuticals, Inc. Irvine Company Experian Hoag Health System UCI Health UCI Health Gavin Herbert Eye Institute UCI Beall Applied Innovation @ the Cove Susan Samueli Integrative Health Institute TrueSpace City of Irvine City of Newport Beach City of Hope
19
-
Brom Rector, CFA
XEIA Venture Partners • 12K followers
Biosphere raised millions from Founders Fund and Lowercarbon Capital to Unleash Industrial Biomanufacturing at scale. Biosphere's cofounder Arye Lipman joined our latest podcast to discuss: - what is biomanufacturing - how Biosphere's UV bioreactors are 10x better than traditional bioreactors - what America with 10x cheaper biomanufacturing looks like - can we grow a steak without a cow? - is biomanufacturing "woke climate" or American Dynamism? - how Biosphere is working with the DOD - MAGA's view on biomanufacturing - Consciousness, dolphins and the CIA Check it out!
6
1 Comment -
Karan Bhatia
Menlo Times • 3K followers
UC Berkeley SkyDeck Ventures in BioTech/MedTech/Life Science. (This round-up is for informational purposes only and in alphabetical order.) 1) AsparaGlue: Led by Paul Birkmeyer, Dr. Thomas H. Jozefiak, Prof. Phillip M., and Dr. Subhajit Pal, Aspara Glue is revolutionizing surgical recovery with an elastic “superglue”. Know More At: asparaglue.com 2) BiomimX® Srl: Led by Paola Occhetta and Marco Rasponi, BiomimX unlocks in vitro models reflecting human complexity, towards the design of effective treatments tailored for patients. Know More At: biomimx.com 3) Cambridge Nucleomics: Led by Prof Ulrich Keyser, Mohammed Alawami, and Dr Hendrik Runge, Cambridge Nucleomics is developing diagnostic tests and life science tools based on a single-molecule RNA-counting platform technology developed in Ulrich Keyser's lab at the University of Cambridge. Know More At: cambridge-nucleomics.com 4) DeepSeq.AI: DeepSeq AI is transforming AI-based protein drug discovery using hyperscaled data. Know More At: deepseq.ai 5) Gisens Biotech: Led by Luis Pierpauli, Jose Maria Piccinini, Maria Florencia Piccinini, Waldemar Marmisolle, Omar Azzaroni, and Esteban Piccinini, Gisens Biotech is revolutionizing diagnostics through nanotechnology. Know More At: gisensbiotech.com 6) NeuraStasis: NeuraStasis is developing the future of stroke care with non-invasive bioelectric medicine. Know More At: neurastasis.com 7) NeuroAge Therapeutics: Led by Dr. Christin Glorioso, MD PHD, NeuroAge Therapeutics is reversing brain aging to prevent dementia. Know More At: neuroagetx.com 8) Olfera: Led by Parnian Lak, Renaud Renault, Kelvin Cooper, Zara Patel, MD, Brian Kopec, Olfera is unlocking the olfactory system's potential for brain disease treatment. Know More At: olferatx.com 9) ReIGNITE Therapeutics, Inc.: Led by Neil Littman, Liliana Maruri Avidal, and others, ReIGNITE Therapeutics is a pioneering biotechnology company leveraging directed evolution, a Nobel Prize-winning technology, to engineer next-generation viral vectors. Know More At: reignitetx.com Post: https://lnkd.in/gT-X7NMY X: https://lnkd.in/gAaJ7gcB Source: https://lnkd.in/gN_2H9Nn
-
Ashis Nayak
Shastra VC • 5K followers
Some of the most enduring technology companies in the US were built on the back of deep academia-led innovation, paired with long-term private capital - especially in areas like semiconductors. That combination created not just companies, but entire industries. We’re beginning to see a similar model take shape in India, and AGNIT is a strong example of that in action. Built on 15+ years of research at IISc, the company brings together a world-class patent portfolio, deep process know-how, and an exceptional founding team that understands the full stack from materials to devices. It’s rare to see this combination of science, IP, and execution come together so tightly. Excited to be part of this journey alongside the team.
21
-
Jakob Diepenbrock
Discipulus Ventures • 4K followers
🇺🇸 The U.S. is the WORLD’S LARGEST consumer of stable isotopes, yet has minimal domestic production capacity — constraining nuclear, pharmaceutical, defense, and other CRITICAL industries. Actinide raised millions out of the last Discipulus Ventures Cohort to build a scalable American isotope platform and ignite the next ATOMIC AGE in America👇 Who Actinide was founded by Eric Olszewski and Robert Mendelsohn Eric is a repeat founder and early Ethereum developer who personally funded $1M+ into Actinide. Robert has spent nearly a decade building isotope separation machines and has prototyped nearly every separator described in the literature. Problem Isotopes unlock advanced materials by changing how substances behave, improving heat transfer, mechanical response, and transport properties through controlled atomic-scale interactions. Yet supply is highly concentrated: Russia dominates many high-value isotopes, while U.S. production capacity remains extremely limited. Solution Actinide rebuilt Manhattan Project–era calutron technology from first principles. Using modern physics simulation, advanced magnetic assemblies, semiconductor-grade components, and in-house manufacturing, Actinide produces isotopes faster and at far lower cost than legacy systems. Vision and Progress Actinide’s first full-scale machine has successfully produced material verified by an independent third-party lab. The company has signed supply agreements across nuclear and pharmaceutical markets, including isotopes priced near $36,000 per gram. Early demand already exceeds current throughput. Hiring Actinide is scaling American manufacturing at the atomic level. They are hiring machinists, metallurgists, control systems engineers, and operators to help build the domestic supply chain for the most valuable materials. Contact: eric@actinideinc.com Discipulus Ventures backs founders tackling America’s hardest problems. If you’re building something ambitious like Actinide, apply to our Cohort: 👉 https://cometogundo.com
70
1 Comment -
Kulika Weizman
Siemens • 5K followers
What an exciting next chapter for our portfolio company, NxLite! NxLite’s nano-scale coatings dramatically improve the energy efficiency of windows and other transparent surfaces. With their new 45,000-square-foot Advanced Innovation & Manufacturing Center now operational in Canton, Michigan, they’re scaling up for commercial production, transforming buildings, vehicles, and more. We at Creative Ventures are proud to support David Mather and the entire NxLite team!
25
1 Comment -
Phil Morle
Main Sequence Ventures • 13K followers
I had a conversation with Karl Schmieder, MS MFA on how #radicalcollaboration is needed to bring a bio-manufacturing industry to life. We talked about: Why invention alone isn’t enough: Discovery is no longer the bottleneck—industrial scaling, regulation, and consumer adoption are. The new role of orchestrators: The most valuable companies will be those that coordinate across supply chains, regulators, and corporates, turning fragmented players into functioning ecosystems. What this means for founders and investors: The future winners in biotech may not be those with the most novel science, but those who master the art of integration. https://lnkd.in/g4bshddA Kylie Porter Michele Stansfield David Weiner David Kestenbaum Mark Warner Sam Perkins Ian O'Hara Arturo Elizondo James Petrie Jim Fader Paul Riley Ed Husic MP Robyn Denholm Guy Reypert Chris Liu Rob Brown Emerald Scofield Dirk van der Kley
47
5 Comments
Explore top content on LinkedIn
Find curated posts and insights for relevant topics all in one place.
View top contentOthers named Terry Moore in United States
-
Terry Moore
United States -
Terry Moore
Mount Pleasant, SC -
Terry Moore
Orange Beach, AL -
Terry Moore
New York City Metropolitan Area
1633 others named Terry Moore in United States are on LinkedIn
See others named Terry Moore